Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

Essai clinique

Radial Shock Wave Treatment Alongside Decongestive Care for Arm Swelling After Breast Cancer

NCT : NCT07862296 · COMPLETED

ID NCTNCT07862296
StatutCOMPLETED
Date de début2022-10-05
Achèvement2024-04-01
SponsorSelcuk University (OTHER)
First posted
Last updated

Résumé succinct

Arm swelling can persist after breast cancer treatment and may interfere with comfort, movement, and everyday activities. Decongestive care combines several approaches to manage this swelling. This study examined whether adding radial shock wave treatment changed short-term outcomes compared with decongestive care alone. Twenty-one adults with stage 2 or stage 3 lymphedema affecting one arm were assigned to two treatment groups. Both groups were allocated to a four-week decongestive program. The combined-treatment schedule also included twelve shock wave sessions. Assessments before and after treatment covered arm size, the thickness of the skin and the tissue beneath it, pain, difficulty using the arm, lymphedema-related quality of life, and shoulder and wrist movement. A physician who did not know the treatment assignment performed the physical and ultrasound measurements.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.

↑